4D Molecular Therapeutics, Inc.
USD9.27
-0.44 (-4.53%)
CEO
David H. Kirn
IPO Date
2020-12-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.52
Prev. Close
$9.71
Day Low
$9.20
Day High
$9.62
52W Low
$3.68
52W High
$12.34
Market Cap
$0.48B
Volume
0.70M
| 217,000 |
| $9.88 |
| 27 Mar 2026 | Simms Christopher Paul | See Remarks | A-Award | Acquired | 219,000 | $9.88 |
| 24 Mar 2026 | Gupta Ashoo | VP, Finance and Controller | M-Exempt | Acquired | 865 | $0.00 |
| 24 Mar 2026 | Gupta Ashoo | VP, Finance and Controller | S-Sale | Disposed | 310 | $8.61 |
| 24 Mar 2026 | Gupta Ashoo | VP, Finance and Controller | M-Exempt | Acquired | 221 | $0.00 |
| 24 Mar 2026 | Gupta Ashoo | VP, Finance and Controller | S-Sale | Disposed | 80 | $8.61 |
| 24 Mar 2026 | Gupta Ashoo | VP, Finance and Controller | M-Exempt | Disposed | 865 | $0.00 |
| 24 Mar 2026 | Gupta Ashoo | VP, Finance and Controller | M-Exempt | Disposed | 221 | $0.00 |
| 7 Jan 2026 | SBLENDORIO GLENN | director | A-Award | Acquired | 45,000 | $7.30 |